Outpatient Mental Health Services / Behavioral Health
Strategic Profile
LifeStance's growth-at-all-cost entry into the public markets is fading as its efficiency efforts bear fruit, with the company posting positive net income for the year for the first time in its history as a public company. Telehealth services account for over 70% of their appointments, enabling scalable delivery. The company is making M&A a priority, with plans to open between 20 and 30 centers in 2026.
Cyborg Score Rationale
The company achieved positive net income of $9.7 million in 2025, a $67.1 million swing from the $57.4 million net loss in 2024, demonstrating operational inflection. However, the company faces ongoing legal challenges including labor law suits and shareholder litigation over clinician retention rates, settled for $50M in 2024. Strong growth trajectory but reputational risks warrant measured confidence.
Top Insights
Revenue for 2025 increased 14% to $1.43 billion, with positive net clinician headcount growth, increased clinician productivity and tech-driven efficiency improvements driving the boost
The board authorized a $100 million stock buyback program, funded with cash on hand and strong balance sheet positioning
The company projects 2026 revenue between $1.615 billion and $1.655 billion (13-16% growth) with adjusted EBITDA between $185-$205 million
The company faces a class-action lawsuit alleging it shared personal patient information with Meta Platforms Inc.
Named Competitors
Telehealth Mental Health Platform — Direct-to-consumer virtual therapy platform
Telehealth Mental Health Platform — Large-scale online counseling and therapy provider
Regional Mental Health Network — Physician-led outpatient mental health services
Primary Care Integration — Mental health integrated with primary care
Recent Developments
(Feb 2026) Filed 10-K report for fiscal year ended December 31, 2025
(Feb 2026) Announced selling stockholders intend to offer 25 million shares under existing shelf registration
(Feb 2026) Achieved first full-year profitability as public company with $9.7M net income, a $67.1M improvement from 2024
Open the full interactive LifeStance Health Group, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.